IAR Premieres Cloud-Enabled Platform Offering for Modern Embedded Software Development Teams

UPPSALA, Sweden--(BUSINESS WIRE)--Mar 11, 2025--

IAR, a leading provider of software solutions for embedded systems development, takes the stage at embedded world 2025 in Nuremberg, Germany, unveiling their brand-new cloud-enabled platform. The new platform gives embedded software developers maximum freedom and flexibility in their tool choice and daily use. IAR’s highly scalable tools package contains the full product offering, including the powerful IAR Embedded Workbench with the proven IAR C/C++ Compiler and IAR Build tools, as well as various premium add-ons like the IAR C-STAT for static code analysis and IAR Embedded Trust for end-to-end security, along with the advanced C-SPY Debugger. With this comprehensive concept, IAR helps customers streamline their tool investment while equipping embedded development teams in automotive, medical, industrial automation, and other sectors with best-in-class tools tailored to their needs.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250311410585/en/

Scale development operations with freedom and flexibility

Traditional licensing agreements often come with reduced flexibility for distributed development teams and limitations regarding supported architectures and processors, leading to additional costs. IAR’s new platform offering promotes modern workflows in embedded software development by supporting distributed teams of varying sizes to collaborate on private, public, and hybrid cloud spaces. Developers gain maximum freedom in their choice of devices and silicon partners, enabling them to build single- and multi-core systems on Arm, RISC-V, and several other legacy architectures, without vendor lock-in.

Simplify compliance & strengthen security

Additional flexibility is also provided when adapting to new and ever-evolving requirements. IAR’s cloud-enabled offering includes tools for implementing functional safety and security features in applications according to standards such as MISRA, IEC, and ISO. These tools are built for developers looking to simplify the complexities of safety- and security-critical projects. With IAR’s support, they can design safe and reliable software that is ready for strict industry-standard certifications.

Accelerate innovation with code confidence

With its comprehensive tools offering packaged into a convenient cloud-ready subscription model, IAR empowers embedded software developers to improve their code’s quality and performance and deploy their software faster. The seamless development workflows enabled by IAR's tools significantly increase efficiency, saving customers time and money and freeing up capacity for further innovation.

“IAR is transitioning from selling individual products with perpetual ownership to offering our entire toolbox in a platform, as a customer-friendly subscription service,” said Cecilia Wachtmeister, CEO of IAR. “The new cloud-enabled offering means lower initial costs for the customer and a high degree of flexibility and customization. Developers have all-access, and can collaborate globally, improve code quality, speed up time-to-market, and improve cost efficiency.”

In addition, since it is cloud-ready the new platform model enables continuous customer dialogue, allowing IAR to respond even faster and more effectively to customer needs and update tools more quickly. To continue delivering value to its customers, IAR will also foster its close cooperation with semiconductor vendors for early device support, long-standing RTOS partners, and major cloud service providers.

To learn about the scope and benefits of IAR’s new cloud-enabled platform, please visit the company’s booth at embedded world (hall 4, stand 4.506). Further information is also available at https://www.iar.com/embedded-development-tools.

About IAR

At IAR, we provide world-leading software and services for embedded development, empowering companies globally to bring secure products that shape the future. Since its founding in 1983, our solutions have been instrumental in ensuring quality, security, reliability, and efficiency in the development of over one million embedded applications for a wide range of industries, including Automotive, Industrial Automation, IoT, MedTech, Military, and Public Safety sectors. With support for 15,000 devices from over 70 semiconductor partners, we are dedicated to fostering innovation and enabling our customers' success.

The company is headquartered in Uppsala, Sweden, with a global presence of sales and support offices strategically located across the world. IAR is an I.A.R. Systems Group AB subsidiary, listed on NASDAQ OMX Stockholm, Mid Cap (ticker symbol: IAR B). To learn more, visit us at www.iar.com.

Next-Level Software Development with the IAR Platform (Photo: Business Wire)

IAR CEO Cecilia Wachtmeister (Photo: Business Wire)

LONDON (AP) — King Charles III has been “deeply touched” by the response to his update on his cancer treatment, Buckingham Palace said Saturday, adding that the monarch is pleased to have highlighted the value of screening programs for the disease.

Medics and health charities have praised the king for his openness, saying his statement on Friday had already prompted people to seek information about cancer.

In a strikingly personal video statement, the British monarch acknowledged that a cancer diagnosis can feel “overwhelming,” but said catching the disease early brings “the precious gift of hope.”

Here’s what to know about the king's condition and his message.

The 77-year-old king said in a statement broadcast Friday that his treatment schedule will be reduced in the new year, “thanks to early diagnosis, effective intervention and adherence to ‘doctors’ orders.’”

He encouraged others to take advantage of screening programs such as those for breast, bowel and cervical cancer offered by Britain’s public health service.

“Early diagnosis quite simply saves lives,” the king said in the statement aired during a “Stand Up to Cancer” telethon on TV station Channel 4. He said catching the disease early had allowed him “to continue leading a full and active life even while undergoing treatment.”

Charles has received outpatient treatment for almost two years. Buckingham Palace did not say the king is in remission, but that his treatment is moving to a “precautionary phase” and his condition will be monitored to ensure his continued recovery.

“I know from my own experience that a cancer diagnosis can feel overwhelming,” the king said in his video statement. “Yet I also know that early detection is the key that can transform treatment journeys, giving invaluable time to medical teams – and, to their patients, the precious gift of hope.”

Charles announced in February 2024 that he had been diagnosed with cancer, and, in a break from centuries of secrecy about royal health, he has since spoken about the illness, using his story to promote cancer awareness and treatment.

The openness has limits, though. The king has not disclosed what type of cancer he has or what kind of treatment he is receiving. The palace said it was an intentional decision designed to ensure his message reaches the widest possible audience.

The king’s cancer was discovered after treatment for an enlarged prostate. While doctors ruled out prostate cancer, tests revealed “a separate issue of concern,” palace officials said last year.

Charles suspended his public appearances for about two months after his diagnosis. Since returning to the public eye, he has visited cancer treatment centers across the country and shared stories with fellow patients.

Buckingham Palace said Charles “will be greatly encouraged and deeply touched by the very positive reaction" his message has generated. “He will be particularly pleased at the way it has helped to shine a light on the benefits of cancer screening programs,” it added.

British cancer charities said the number of people seeking information about cancer jumped after the king revealed he was undergoing treatment last year.

Cancer Research U.K. said about 100,000 people have visited its Screening Checker website since it was launched on Dec. 5, most of them since the king’s statement on Friday.

The charity's Chief Executive Michelle Mitchell said: “When public figures speak openly about their cancer diagnosis, it can prompt others to check in on their health.”

Broadcaster Jonathan Dimbleby, the king’s authorized biographer, said the statement was “a remarkable thing for a monarch to do.”

“It takes guts, and the fact that he came out and did that will save lives,’” Dimbleby said.

The Princess of Wales, who announced her own cancer diagnosis six weeks after her father-in-law, has also given updates on her treatment. Kate announced in January that her cancer is in remission.

Find more of AP’s coverage at https://apnews.com/hub/royalty

Britain's King Charles III attends an Advent Service at Westminster Abbey, in London, Wednesday, Dec. 10, 2025. (Chris Jackson/Pool Photo via AP)

Britain's King Charles III attends an Advent Service at Westminster Abbey, in London, Wednesday, Dec. 10, 2025. (Chris Jackson/Pool Photo via AP)